|
|
|
|
Science Sparks @ ACTREC
|
 08th July 2024 |
Vol. No. 13 ; Issue No.638 |
|
|
|
|
|
|
Interesting Reads
|
|
Neumann EN, Bertozzi TM, Wu E, Serack F, Harvey JW, Brauer PP, Pirtle CP, Coffey A, Howard M, Kamath N, Lenz K, Guzman K, Raymond MH, Khalil AS, Deverman BE, Minikel EV, Vallabh SM, Weissman JS. Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor. Science. 384(6703): ado7082.
|
|
|
Video of the Week
|
|
| Management of Facial Palsy Using Head and Neck Cancer Therapy |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1996, First demonstration was made that blocking CTLA-4 could enhance antitumor immunity and lead to tumor elimination.
|
|
|
|
Cancer News
|
| |
|
RNA splicing strategy corrects tumor suppressor gene in neuroendocrine cancers.
|
|
MedicalXpress, 03/07/2024
|
|
Researchers focused on a protein named the RE1-silencing transcription factor (REST), which typically represses certain genes that support neuroendocrine phenotypes. Interestingly, an abnormally spliced form of REST mRNA is expressed at high levels in neuroendocrine tumors...
|
| |
|
AI model to improve patient response to cancer therapy.
|
|
Eurekalert, 03/07/2024
|
|
DeepPT, developed in collaboration with scientists at the National Cancer Institute in America and pharmaceutical company Pangea Biomed, works by predicting a patient’s messenger RNA (mRNA) profile. This mRNA, essential for protein production...
|
|
|
|
|
| |
|
|
|
Turning cancer cells against themselves to overcome drug resistance.
|
|
News-Medical, 04/07/2024
|
|
Researchers created a modular genetic circuit that turns cancer cells into a "Trojan horse," causing them to self-destruct and kill nearby drug-resistant cancer cells. Tested in human cell lines and in mice as proof of concept, the circuit outsmarted a wide range of resistance...
|
|
|
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
